Hanson McClain Advisors »

Rapport Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $126 4 31.50
2025-03-31 $166 15 11.13

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds State Street Spd (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Hanson McClain Advisors

Top funds holding Rapport Therapeutics

FMR
TRV GP V
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Johnson & Johnson
Polar Capital Holdings
Baker Bros. Advisors
Vestal Point Capital
Vanguard Capital Management
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics